Icariin alters the expression of glucocorticoid receptor, FKBP5 and SGK1 in rat brains following exposure to chronic mild stress

Wei,Kai; Xu,Yizhe; Zhao,Zhengxiao; Wu,Xiao; Du,Yijie; Sun,Jing; Yi,Tao; Dong,Jingcheng; Liu,Baojun

doi:10.3892/ijmm.2016.2591

Icariin alters the expression of glucocorticoid receptor, FKBP5 and SGK1 in rat brains following exposure to chronic mild stress

Authors:
- Kai Wei
- Yizhe Xu
- Zhengxiao Zhao
- Xiao Wu
- Yijie Du
- Jing Sun
- Tao Yi
- Jingcheng Dong
- Baojun Liu
View Affiliations

Affiliations: Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China
Published online on: May 17, 2016 https://doi.org/10.3892/ijmm.2016.2591
Pages: 337-344

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Icariin, a flavonoid and a major constituent of Herba Epimedii, has been previously demonstrated to possess potential antidepressant-like effects. In the present study, we established a rat model of depression induced by unpredictable chronic mild stress (CMS) in order to examine the effects of icariin treatment. The rats were allocated into the control group or one of the treatment groups [exposure to CMS plus oral administration of saline, icariin (20 or 40 mg/kg) or fluoxetine (10mg/kg)]. We examined the therapeutic effects of icariin administration on depression‑like behaviors (with a sucrose preference test), on the mRNA and protein expression of glucocorticoid receptor (GR), FK506 binding protein 5 (FKBP5) and serum- and glucocorticoid-inducible kinase 1 (SGK1), as well as on the distribution of GR (in the cytoplasm and nucleus) in both the hippocampus and the prefrontal cortex following exposure to CMS. Our results revealed that the oral administration of icariin (20 and 40 mg/kg) for 35 consecutive days attenuated the development of depression-like behaviors induced by exposure to CMS. The increased mRNA expression of GR and SGK1 in the prefrontal cortex was reversed by icariin treatment. Moreover, the CMS-induced increases in the levels of cytosolic GR and SGK1 were partially restored by icariin administration in both the hippocampus and the prefrontal cortex, particularly in the hippocampus. Icariin also partially reversed the upregulated epxression of nuclear GR in the prefrontal cortex and that of FKBP5 in the hippocampus. On the whole, our findings indicate that icariin may have therapeutic applications as a potential antidepressant with multiple targets in both the hippocampus and prefrontal cortex. It exerts antidepressant-like effects by restoring the negative feedback regulation of the hypothalamic-pituitary-adrenal axis, which is at least partially attributed to normalization of the distribution of GR, and decreases in the expression levels of FKBP5 and SGK1.

View Figures

View References

1	Guidotti G, Calabrese F, Anacker C, Racagni G, Pariante CM and Riva MA: Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology. 38:616–627. 2013. View Article : Google Scholar :
2	McEwen BS, Gould EA and Sakai RR: The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. Br J Psychiatry Suppl. 15:18–23. 1992.PubMed/NCBI
3	Tatro ET, Everall IP, Kaul M and Achim CL: Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder. Brain Res. 1286:1–12. 2009. View Article : Google Scholar : PubMed/NCBI
4	Adzic M, Djordjevic J, Djordjevic A, Niciforovic A, Demonacos C, Radojcic M and Krstic-Demonacos M: Acute or chronic stress induce cell compartment-specific phosphorylation of glucocor-ticoid receptor and alter its transcriptional activity in Wistar rat brain. J Endocrinol. 202:87–97. 2009. View Article : Google Scholar : PubMed/NCBI
5	Sapolsky RM, Romero LM and Munck AU: How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 21:55–89. 2000.PubMed/NCBI
6	Pariante CM: Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Ann NY Acad Sci. 1179:144–152. 2009. View Article : Google Scholar : PubMed/NCBI
7	Binder EB: The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology. 34(Suppl 1): S186–S195. 2009. View Article : Google Scholar : PubMed/NCBI
8	Wochnik GM, Rüegg J, Abel GA, Schmidt U, Holsboer F and Rein T: FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem. 280:4609–4616. 2005. View Article : Google Scholar
9	Miyata S, Koyama Y, Takemoto K, Yoshikawa K, Ishikawa T, Taniguchi M, Inoue K, Aoki M, Hori O, Katayama T and Tohyama M: Plasma corticosterone activates SGK1 and induces morphological changes in oligodendrocytes in corpus callosum. PLoS One. 6:e198592011. View Article : Google Scholar : PubMed/NCBI
10	Lang F, Strutz-Seebohm N, Seebohm G and Lang UE: Significance of SGK1 in the regulation of neuronal function. J Physiol. 588:3349–3354. 2010. View Article : Google Scholar : PubMed/NCBI
11	Anacker C, Cattaneo A, Musaelyan K, Zunszain PA, Horowitz M, Molteni R, Luoni A, Calabrese F, Tansey K, Gennarelli M, et al: Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. Proc Natl Acad Sci USA. 110:8708–8713. 2013. View Article : Google Scholar : PubMed/NCBI
12	Djordjevic A, Adzic M, Djordjevic J and Radojcic MB: Stress type dependence of expression and cytoplasmic-nuclear partitioning of glucocorticoid receptor, hsp90 and hsp70 in Wistar rat brain. Neuropsychobiology. 59:213–221. 2009. View Article : Google Scholar : PubMed/NCBI
13	Wu X, Wu J, Xia S, Li B and Dong J: Icaritin opposes the development of social aversion after defeat stress via increases of GR mRNA and BDNF mRNA in mice. Behav Brain Res. 256:602–608. 2013. View Article : Google Scholar : PubMed/NCBI
14	Li B, Duan X, Xu C, Wu J, Liu B, Du Y, Luo Q, Jin H, Gong W and Dong J: Icariin attenuates glucocorticoid insensitivity mediated by repeated psychosocial stress on an ovalbumin-induced murine model of asthma. Int Immunopharmacol. 19:381–390. 2014. View Article : Google Scholar : PubMed/NCBI
15	Liu B, Xu C, Wu X, Liu F, Du Y, Sun J, Tao J and Dong J: Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation. Neuroscience. 294:193–205. 2015. View Article : Google Scholar : PubMed/NCBI
16	Liu B, Zhang H, Xu C, Yang G, Tao J, Huang J, Wu J, Duan X, Cao Y and Dong J: Neuroprotective effects of icariin on corticosterone-induced apoptosis in primary cultured rat hippocampal neurons. Brain Res. 1375:59–67. 2011. View Article : Google Scholar
17	Pan Y, Wang FM, Qiang LQ, Zhang DM and Kong LD: Icariin attenuates chronic mild stress-induced dysregulation of the LHPA stress circuit in rats. Psychoneuroendocrinology. 35:272–283. 2010. View Article : Google Scholar
18	Pan Y, Zhang WY, Xia X and Kong LD: Effects of icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague-Dawley rats. Biol Pharm Bull. 29:2399–2403. 2006. View Article : Google Scholar : PubMed/NCBI
19	Pan Y, Kong LD, Li YC, Xia X, Kung HF and Jiang FX: Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats. Pharmacol Biochem Behav. 87:130–140. 2007. View Article : Google Scholar : PubMed/NCBI
20	Hill MN, Hellemans KG, Verma P, Gorzalka BB and Weinberg J: Neurobiology of chronic mild stress: parallels to major depression. Neurosci Biobehav Rev. 36:2085–2117. 2012. View Article : Google Scholar : PubMed/NCBI
21	Calabrese F, Guidotti G, Molteni R, Racagni G, Mancini M and Riva MA: Stress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatment. PLoS One. 7:e379162012. View Article : Google Scholar : PubMed/NCBI
22	Maccari S, Mormède P, Piazza PV, Simon H, Angelucci L and Le Moal M: Hippocampal type I and type II corticosteroid receptors are modulated by central noradrenergic systems. Psychoneuroendocrinology. 17:103–112. 1992. View Article : Google Scholar : PubMed/NCBI
23	Pavlides C, Watanabe Y, Magariños AM and McEwen BS: Opposing roles of type I and type II adrenal steroid receptors in hippocampal long-term potentiation. Neuroscience. 68:387–394. 1995. View Article : Google Scholar : PubMed/NCBI
24	Webster MJ, Knable MB, O'Grady J, Orthmann J and Weickert CS: Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry. 7:985–994. 9242002. View Article : Google Scholar : PubMed/NCBI
25	Zheng H, Liu Y, Li W, Yang B, Chen D, Wang X, Jiang Z, Wang H, Wang Z, Cornelisson G and Halberg F: Beneficial effects of exercise and its molecular mechanisms on depression in rats. Behav Brain Res. 168:47–55. 2006. View Article : Google Scholar
26	Li M, Fu Q, Li Y, Li S, Xue J and Ma S: Emodin opposes chronic unpredictable mild stress induced depressive-like behavior in mice by upregulating the levels of hippocampal glucocorticoid receptor and brain-derived neurotrophic factor. Fitoterapia. 98:1–10. 2014. View Article : Google Scholar : PubMed/NCBI
27	Skupio U, Tertil M, Sikora M, Golda S, Wawrzczak-Bargiela A and Przewlocki R: Behavioral and molecular alterations in mice resulting from chronic treatment with dexamethasone: relevance to depression. Neuroscience. 286:141–150. 2015. View Article : Google Scholar
28	Moutsatsou P, Psarra AM, Tsiapara A, Paraskevakou H, Davaris P and Sekeris CE: Localization of the glucocorticoid receptor in rat brain mitochondria. Arch Biochem Biophys. 386:69–78. 2001. View Article : Google Scholar : PubMed/NCBI
29	Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, Khairova R, Zhou R, Yuan P, Machado-Vieira R, et al: Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci USA. 106:3543–3548. 2009. View Article : Google Scholar : PubMed/NCBI
30	Xing Y, He J, Hou J, Lin F, Tian J and Kurihara H: Gender differences in CMS and the effects of antidepressant venlafaxine in rats. Neurochem Int. 63:570–575. 2013. View Article : Google Scholar : PubMed/NCBI
31	Xing Y, Hou J, Meng Q, Yang M, Kurihara H and Tian J: Novel antidepressant candidate RO-05 modulated glucocorticoid receptors activation and FKBP5 expression in chronic mild stress model in rats. Neuroscience. 290:255–265. 2015. View Article : Google Scholar : PubMed/NCBI
32	Webster MK, Goya L, Ge Y, Maiyar AC and Firestone GL: Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol. 13:2031–2040. 1993. View Article : Google Scholar : PubMed/NCBI
33	Cai C, Thorne J and Grabel L: Hedgehog serves as a mitogen and survival factor during embryonic stem cell neurogenesis. Stem Cells. 26:1097–1108. 2008. View Article : Google Scholar : PubMed/NCBI
34	Feng Z, Liu L, Zhang C, Zheng T, Wang J, Lin M, Zhao Y, Wang X, Levine AJ and Hu W: Chronic restraint stress attenuates p53 function and promotes tumorigenesis. Proc Natl Acad Sci USA. 109:7013–7018. 2012. View Article : Google Scholar : PubMed/NCBI